Concordare closes pre-seed round

Concordare has closed a pre-seed round to expand our team and accelerate improvements to the CTPM platform. The funding will support further product integrations, team expansion, and the continued growth of Concordare’s site partnership network.

We are always excited to connect with people who are passionate about clinical research and the technology that can transform it. If that sounds like you, we’d love to hear from you.

Related posts

• 
  Company News

  Concordare Submits Public Comment to FDA on the Expedited IND Pilot Program

  July 2026 · 2 min read
• 
  Company News

  Concordare Named Finalist in 2026 Fierce AI Innovation Awards

  July 2026
• 
  Product Update

  Audit of Concordare's Digital Protocol AI Conversion Engine Achieves 99.6% Accuracy

  July 2026 · 3 min read